1
Leamon Christopher Paul, Wang Yu, Vlahov Iontcho Radoslavov, You Fei, Kleindl Paul Joseph, Santhapuram Hari Krishna R: Conjugates containing hydrophilic spacer linkers. Endocyte, Leamon Christopher Paul, Wang Yu, Vlahov Iontcho Radoslavov, You Fei, Kleindl Paul Joseph, Santhapuram Hari Krishna R, BALL Rebecca L, December 31, 2008: WO/2009/002993 (38 worldwide citation)

Described herein are compositions and methods for use in targeted drug delivery using cell- surface receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations.


2
Christopher Paul Leamon, Iontcho Radoslavov Vlahov, Hari Krishna R Santhapuram, Paul Joseph Kleindl, Yu Wang, Fei You: Conjugates containing hydrophilic spacer linkers. Endocyte, Barnes & Thornburg, September 22, 2015: US09138484 (2 worldwide citation)

Described herein are compositions and methods for use in targeted drug delivery using cell receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in imaging, diagnosing, and/or treating diseases and disease states caused by pathogenic cell populations.


3
LEAMON CHRISTOPHER PAUL: Vitamin receptor drug delivery conjugates for treating inflammation. ENDOCYTE, Ball Rebecca L, June 30, 2011: WO/2011/079227 (1 worldwide citation)

Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.


4
Christopher Paul Leamon, Iontcho Radoslavov Vlahov, Yingjuan June Lu, Kevin Yu Wang, Fei Yu, Paul Joseph Kleindl, Hari Krishna R Santhapuram: Vitamin receptor drug delivery conjugates for treating inflammation. Endocyte, Barnes & Thornburg, January 30, 2018: US09877965

Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.


5
Christopher Paul Leamon, Iontcho Radoslavov Vlahov, Hari Krishna R Santhapuram, Paul Joseph Kleindl, Yu Wang, Fei You: Conjugates containing hydrophilic spacer linkers. Endoctye, Barnes & Thornburg, December 23, 2010: US20100323973-A1

Described herein are compositions and methods for use in targeted drug delivery using cell receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in imaging, diagnosing, and/or treating diseases and disease states caused by pathogenic cell populations.


6

7
Leamon Christopher Paul, Wang Yu, Vlahov Iontcho Radoslavov, You Fei, Kleindl Paul Joseph, Santhapuram Hari Krishna R: Conjugates containing hydrophilic spacer linkers. Endocyte, Quan Lujun, Guo Wenji, July 21, 2010: CN200880104308

Described herein are compositions and methods for use in targeted drug delivery using cell- surface receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations.


8
Christopher Paul Leamon, Iontcho Radoslavov Vlahov, Yingjuan June Lu: Vitamin receptor drug delivery conjugates for treating inflammation. Endocyte, October 11, 2012: US20120258905-A1

Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.


9
CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS. ENDOCYTE, March 13, 2014: US20140073761-A1

Described herein are compositions and methods for use in targeted drug delivery using cell receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in imaging, diagnosing, and/or treating diseases and disease states caused by pathogenic cell populations.


10
VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION. November 5, 2015: US20150314015-A1

Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.